Ann: Trading Halt, page-120

Let's sell the medical device where they accept CE and TGA approval then and than wait for the OSA diagnosis and COPD and asthma respiratory disease management products to be commercialise as well and maybe ignore US all together and focus on the China market, they will be more wary of respiratory disease after COVID-19 with telehealth BOOM after it and will be a huge market for COPD respiratory management, there is a lot of smoker with very poor air quality there.